Cancer Drug Flushes Out Lurking AIDS Virus: Study
July 27, 2012
In a tentative first step toward a possible AIDS cure, U.S. researchers have used the cancer drug vorinostat to revive and unmask latent HIV in clinical trial patients' immune cells. The ability of the HIV genome, or reproductive code, to hide out in cells only and revive after decades has posed a major obstacle to a cure. Exposing the virus in its hiding place would allow scientists to target and destroy its host white blood cells: CD4+T cells.
Is the "Berlin Patient" No Longer Alone? Stem Cell Transplant Appears to Clear HIV in Two Men on Treatment
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.